Terns (TERN) Hits All-Time High on Stellar Leukemia Treatment Results

We recently published 10 Stocks Standing Tall Amid Market Fall; 6 Hit Record Highs. Terns Pharmaceuticals, Inc. (NASDAQ:TERN) is one of the best performers on Monday. Terns soared to a new all-time high on Monday as investors took heart from the encouraging results of its clinical trial to test the efficacy of drug candidate, TERN-701, in patients with previously treated chronic myeloid leukemia (CML). At intra-day trading, the stock climbed to its highest price of $45 before trimming gains to finish the ...